MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wing, M. R.
Right arrow Articles by Harden, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wing, M. R.
Right arrow Articles by Harden, T. K.
Molecular Interventions 3:273-280 (2003)
© 2003 American Society of Pharmacology and Experimental Therapeutics


Review

PLC-{varepsilon}: A Shared Effector Protein in Ras-, Rho-, and G{alpha}ß{gamma}-Mediated Signaling

Michele R. Wing, David M. Bourdon and T. Kendall Harden

Department of Pharmacology University of North Carolina School of Medicine Chapel Hill, NC 27599

Correspondence: Address correspondence to TKH. E-mail tkh{at}med.unc.edu; fax 919-966-5640.


The conceptual segregation of G protein–stimulated cell signaling responses into those mediated by heterotrimeric G proteins versus those promoted by small GTPases of the Ras superfamily is no longer vogue. PLC-{varepsilon} , an isozyme of the phospholipase C (PLC) family, has been identified recently and dramatically extends our understanding of the crosstalk that occurs between heterotrimeric and small monomeric GTPases. Like the widely studied PLC-ß isozymes, PLC-{varepsilon} is activated by Gß{gamma} released upon activation of heterotrimeric G proteins. However, PLC-{varepsilon} markedly differs from the PLC-ß isozymes in its capacity for activation by G{alpha}12/13 - but not G{alpha}q -coupled receptors. PLC-{varepsilon} contains two Ras-associating domains located near the C terminus, and H-Ras regulates PLC-{varepsilon} as a downstream effector. Rho also activates PLC-{varepsilon} , but in a mechanism independent of the C-terminal Ras-associating domains. Therefore, Ca2+ mobilization and activation of protein kinase C are signaling responses associated with activation of both H-Ras and Rho. A guanine nucleotide exchange domain conserved in the N terminus of PLC-{varepsilon} potentially confers a capacity for activators of this isozyme to cast signals into additional signaling pathways mediated by GTPases of the Ras superfamily. Thus, PLC-{varepsilon} is a multifunctional nexus protein that senses and mediates crosstalk between heterotrimeric and small GTPase signaling pathways.


Related articles in MI:

Sites of interest on the World Wide Web - edited by David Siderovski

MI 2003 3: 293. [Full Text]  



This article has been cited by other articles:


Home page
J. Neurosci.Home page
I. Gekel and E. Neher
Application of an Epac Activator Enhances Neurotransmitter Release at Excitatory Central Synapses
J. Neurosci., August 6, 2008; 28(32): 7991 - 8002.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Gbadegesin, B. G. Hinkes, B. E. Hoskins, C. N. Vlangos, S. F. Heeringa, J. Liu, C. Loirat, F. Ozaltin, S. Hashmi, F. Ulmer, et al.
Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS)
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1291 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Chaib, B. E. Hoskins, S. Ashraf, M. Goyal, R. C. Wiggins, and F. Hildebrandt
Identification of BRAF as a new interactor of PLC{varepsilon}1, the protein mutated in nephrotic syndrome type 3
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F93 - F99.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. R. J. Bois
A Highly Polymorphic Meiotic Recombination Mouse Hot Spot Exhibits Incomplete Repair
Mol. Cell. Biol., October 15, 2007; 27(20): 7053 - 7062.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Citro, S. Malik, E. A. Oestreich, J. Radeff-Huang, G. G. Kelley, A. V. Smrcka, and J. H. Brown
Phospholipase C{varepsilon} is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation
PNAS, September 25, 2007; 104(39): 15543 - 15548.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. Bertagnolo, M. Benedusi, F. Brugnoli, P. Lanuti, M. Marchisio, P. Querzoli, and S. Capitani
Phospholipase C-{beta}2 promotes mitosis and migration of human breast cancer-derived cells
Carcinogenesis, August 1, 2007; 28(8): 1638 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Piechulek, T. Rehlen, C. Walliser, P. Vatter, B. Moepps, and P. Gierschik
Isozyme-specific Stimulation of Phospholipase C-{gamma}2 by Rac GTPases
J. Biol. Chem., November 25, 2005; 280(47): 38923 - 38931.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. A. Gollob, C. J. Sciambi, Z. Huang, and H. K. Dressman
Gene Expression Changes and Signaling Events Associated with the Direct Antimelanoma Effect of IFN-{gamma}
Cancer Res., October 1, 2005; 65(19): 8869 - 8877.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. Diverse-Pierluissi
G Protein Effectors
Sci. Signal., April 26, 2005; 2005(281): tr13 - tr13.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Bai, H. Edamatsu, S. Maeda, H. Saito, N. Suzuki, T. Satoh, and T. Kataoka
Crucial Role of Phospholipase C{epsilon} in Chemical Carcinogen-Induced Skin Tumor Development
Cancer Res., December 15, 2004; 64(24): 8808 - 8810.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
P. T. Ivanova, S. B. Milne, J. S. Forrester, and H. A. Brown
LIPID Arrays: New Tools in the Understanding of Membrane Dynamics and Lipid Signaling
Mol. Interv., April 1, 2004; 4(2): 86 - 96.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.